Pulse Biosciences (NASDAQ:PLSE) Trading Up 6.7% – Should You Buy?

Shares of Pulse Biosciences, Inc. (NASDAQ:PLSE) rose 6.7% during trading on Friday . The stock traded as high as $17.49 and last traded at $17.60. Approximately 60,299 shares were traded during mid-day trading, a decline of 69% from the average daily volume of 196,835 shares. The stock had previously closed at $16.49.

Analyst Ratings Changes

Separately, StockNews.com raised shares of Pulse Biosciences to a “sell” rating in a research note on Monday, March 31st.

Pulse Biosciences Trading Up 4.2%

The business has a fifty day simple moving average of $16.57 and a 200 day simple moving average of $17.98.

Pulse Biosciences (NASDAQ:PLSE) last issued its quarterly earnings data on Thursday, May 8th. The company reported ($0.25) earnings per share (EPS) for the quarter.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in PLSE. Invesco Ltd. raised its position in shares of Pulse Biosciences by 1,956.7% in the fourth quarter. Invesco Ltd. now owns 214,490 shares of the company’s stock valued at $3,734,000 after buying an additional 204,061 shares during the last quarter. Vanguard Group Inc. raised its holdings in Pulse Biosciences by 15.1% in the 4th quarter. Vanguard Group Inc. now owns 1,146,339 shares of the company’s stock valued at $19,958,000 after acquiring an additional 150,506 shares during the last quarter. Nuveen LLC acquired a new position in Pulse Biosciences in the 1st quarter valued at $915,000. Pandora Wealth Inc. purchased a new position in shares of Pulse Biosciences during the 1st quarter worth $828,000. Finally, Panoramic Capital LLC acquired a new stake in shares of Pulse Biosciences during the fourth quarter worth $846,000. 76.95% of the stock is currently owned by hedge funds and other institutional investors.

About Pulse Biosciences

Pulse Biosciences, Inc operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology.